Ortho Evra (Janssen Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the Ortho Evra drug offered from Janssen Pharmaceutical, Inc.. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Janssen Pharmaceutical, Inc.
NON-PROPRIETARY NAME: norelgestromin and ethinyl estradiol
SUBSTANCE NAME: NORELGESTROMIN; ETHINYL ESTRADIOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA]
ROUTE: TRANSDERMAL
DOSAGE FORM: PATCH, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2001-11-20
END MARKETING DATE: 0000-00-00


Ortho Evra HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOrtho Evra from Janssen Pharmaceutical, Inc.
LABELER NAME: Janssen Pharmaceutical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 150; 35(ug/d; ug/d)
START MARKETING DATE: 2001-11-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50458-192_91d2e319-86db-4f6d-bdf9-81795d6cf722
PRODUCT NDC: 50458-192
APPLICATION NUMBER: NDA021180

Other NORELGESTROMIN; ETHINYL ESTRADIOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Janssen Pharmaceutical, Inc.Ortho Evra
Mylan Pharmaceuticals Inc.XULANE